Clinical Cardiac Pacing, Defibrillation and Resynchronization Therapy

Neural and Spinal Stimulation

Acknowledgment: This work was supported by the Research Grants Council of Hong Kong, General Research Fund (No. HKU 7801/10M, HKU 7811/11M). Introduction Heart failure (HF) is a substantial cause of mortality, morbidity, and health care expenditure worldwide. The burden of…

The Biological Pacemaker

In October 1958, the first fully internalized pacemaker was implanted at the Karolinska Institute in Sweden. Within hours, the unit ceased to function, or as Senning wrote in a retrospective account “at 2 am the pacemaker became silent.” When searching…

Leadless Pacing

Implantable cardiac pacing was born in 1958 and has never stopped evolving since. The contribution of new advances has been dramatic in this development, especially over the last 25 years, because of the introduction of electronics and the progress in…

Pacing and Defibrillation Use in Pediatric Patients

Permanent cardiac pacemakers and implantable cardioverter defibrillators have been used in children for over half a century. There are several important differences in device usage between children and adults. Children are not only physically smaller than adults, but they also…

Cardiac Resynchronization Therapy

The number of patients with chronic heart failure is increasing rapidly throughout the industrialized economies of the world. The majority of the expense for the management of patients with heart failure (HF) is mostly related to hospitalizations. In the United…

Subcutaneous and Epicardial Defibrillators

Implantable cardioverter-defibrillators (ICDs) are the most effective means for treatment of ventricular arrhythmias and prevention of sudden cardiac death. In their early use, ICDs were implanted for secondary prevention in those patients who were survivors of sustained ventricular arrhythmias or…

Defibrillation Therapy

Over the last few decades cardiovascular mortality and sudden cardiac death (SCD) have gradually declined due to improvements in management of patients at risk with advent of primary coronary interventions, widespread use of statins, angiotensin-converting enzyme (ACE) inhibitors, and β-blockers.…

Pacing in Reflex (Neurally-Mediated) Syncopes

The Clinical Spectrum of Reflex Syncopes Reflex syncope (synonym: neurally-mediated [reflex] syncope ) refers to a reflex response that, when triggered, gives rise to vaso-/venodilation and/or bradycardia; however, the contribution of each of these two factors to systemic hypotension and…